Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/17077358

J. Natl. Cancer Inst. 2006 Nov 1 98 21 1558-70

Download in:

View as

Triples

General Info

PMID
17077358